This protocol is judged by an institutional evaluation board, an unbiased team that testimonials any medical trials involving individuals. If a study entails a Agenda I drug, as soon as the board approves the protocol as ethical, the researchers must make an application for an investigational new drug (IND) number within the FDA.When under the aff